GlaxoSmithKline offloads Polish plant with 700 workers to French CDMO Delpharm
With plans to take its consumer healthcare joint venture with Pfizer public in the next few years, GlaxoSmithKline has been in Marie Kondo mode for some of its expansive global assets. After cutting a Canadian plant with 400 workers earlier this year, GSK is now hiving off an even bigger facility in Poland. GSK has sold… Read More »